New hip implant studied for better joint replacement outcomes
NCT ID NCT06564636
First seen Nov 01, 2025 · Last updated Jun 09, 2026 · Updated 19 times
Summary
This study looks at how well a new hip replacement system, called CATALYSTEM, works in 119 people who need a total hip replacement due to conditions like arthritis or bone damage. The main goal is to see if the implant stays in place without problems for at least 2 years. Researchers will also track patients' pain and function using surveys.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Concordia General Hospital
Winnipeg, Manitoba, R2K 2M9, Canada
-
Connecticut Orthopaedic Institute
Hamden, Connecticut, 06518, United States
-
Duke Health
Morrisville, North Carolina, 27560, United States
-
Illinois Bone and Joint Institute
Des Plaines, Illinois, 60016, United States
-
London Health Sciences Centre (LHSC)
London, Ontario, N6A 5A5, Canada
-
NYU Langone Health Orthopedic Hospital
New York, New York, 10003, United States
-
Orlando Health Inc.
Orlando, Florida, 32806, United States
-
University of Alberta
Edmonton, Alberta, T6G 2B7, Canada
-
University of British Columbia
Vancouver, British Columbia, V5Z 1M9, Canada
-
University of California at San Francisco
San Francisco, California, 94158, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.